Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19-Reply

被引：0
|
作者：
Vandebosch, An [1 ]
Sadoff, Jerald [2 ]
Douoguih, Macaya [2 ]
机构：
[1] Janssen Res & Dev, Beerse, Belgium
[2] Janssen Vaccines & Prevent, Leiden, Netherlands
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2021年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP
    Solforosi, Laura
    Kuipers, Harmjan
    Jongeneelen, Mandy
    Huber, Sietske K. Rosendahl
    van der Lubbe, Joan E. M.
    Dekking, Liesbeth
    Czapska-Casey, Dominika N.
    Gil, Ana Izquierdo
    Baert, Miranda R. M.
    Drijver, Joke
    Vaneman, Joost
    van Huizen, Ella
    Choi, Ying
    Vreugdenhil, Jessica
    Kroos, Sanne
    de Wilde, Adriaan H.
    Kourkouta, Eleni
    Custers, Jerome
    van der Vlugt, Remko
    Veldman, Daniel
    Huizingh, Jeroen
    Kaszas, Krisztian
    Dalebout, Tim J.
    Myeni, Sebenzile K.
    Kikkert, Marjolein
    Snijder, Eric J.
    Barouch, Dan H.
    Boszormenyi, Kinga P.
    Stammes, Marieke A.
    Kondova, Ivanela
    Verschoor, Ernst J.
    Verstrepen, Babs E.
    Koopman, Gerrit
    Mooij, Petra
    Bogers, Willy M. J. M.
    van Heerden, Marjolein
    Muchene, Leacky
    Tolboom, Jeroen T. B. M.
    Roozendaal, Ramon
    Brandenburg, Boerries
    Schuitemaker, Hanneke
    Wegmann, Frank
    Zahn, Roland C.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (07):
  • [22] Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome
    Li, Hai-Feng
    Hu, Shi-Min
    Lv, Ming
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (04): : 392 - +
  • [23] Acute disseminated encephalomyelitis following the COVID-19 vaccine Ad26.COV2.S, a case report
    Stefan Gustavsen
    Mette Maria Nordling
    Arkadiusz Weglewski
    Bulletin of the National Research Centre, 47 (1)
  • [24] Massive bullous local reaction following administration of Ad26.COV2.S COVID-19 vaccine
    Montero-Menarguez, Julia
    Falkenhain-Lopez, Daniel
    Guzman-Perez, Luisa Maria
    Rodriguez-Peralto, Jose Luis
    Tous-Romero, Fatima
    Gallego-Alvarez, Silvia
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (05) : 636 - 638
  • [25] Quantifying Antibody Persistence After a Single Dose of COVID-19 Vaccine Ad26.COV2.S in Humans Using a Mechanistic Modeling and Simulation Approach
    Dari, Anna
    Boulton, Muriel
    Neyens, Martine
    Le Gars, Mathieu
    Valenzuela, Belen
    Shukarev, Georgi
    Cardenas, Vicky
    Ruiz-Guinazu, Javier
    Sadoff, Jerald
    Hoetelmans, Richard M. W.
    Ruixo, Juan Jose Perez
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (02) : 380 - 389
  • [26] Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine
    Sadoff, J.
    Le Gars, M.
    Shukarev, G.
    Heerwegh, D.
    Truyers, C.
    de Groot, A. M.
    Stoop, J.
    Tete, S.
    Van Damme, W.
    Leroux-Roels, I
    Berghmans, P-J
    Kimmel, M.
    Van Damme, P.
    de Hoon, J.
    Smith, W.
    Stephenson, K. E.
    De Rosa, S. C.
    Cohen, K. W.
    McElrath, M. J.
    Cormier, E.
    Scheper, G.
    Barouch, D. H.
    Hendriks, J.
    Struyf, F.
    Douoguih, M.
    Van Hoof, J.
    Schuitemaker, H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (19): : 1824 - 1835
  • [27] Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations
    Botton, Jeremie
    Semenzato, Laura
    Jabagi, Marie-Joelle
    Baricault, Berangere
    Weill, Alain
    Dray-Spira, Rosemary
    Zureik, Mahmoud
    JAMA NETWORK OPEN, 2022, 5 (03)
  • [28] Bell's palsy following the Ad26.COV2.S COVID-19 vaccination
    Nishizawa, Y.
    Hoshina, Y.
    Baker, V
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2021, 114 (09) : 657 - 658
  • [29] Comment on "Oral lichen planus following the administration of vector based COVID-19 vaccine (Ad26.COV2.S)". Authors' reply
    Troeltzsch, Matthias
    Berndt, Ronald
    Troeltzsch, Markus
    ORAL DISEASES, 2022, 28 : 2610 - 2611
  • [30] The single-dose Janssen Ad26.COV2.S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort
    Serwanga, Jennifer
    Kato, Laban
    Oluka, Gerald Kevin
    Ankunda, Violet
    Sembera, Jackson
    Baine, Claire
    Kitabye, Isaac
    Namuyanja, Angela
    Opio, Solomon
    Katende, Joseph Ssebwana
    Ejou, Peter
    Kaleebu, Pontiano
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345